In another report, a 63-year-old man with an ACTH-secreting pituitary carcinoma was treated with a combination of radiotherapy, temozolomide, and bevacizumab 6 weeks after surgical resection; 5 years later, he was alive and had no recurrence of his tumor [67]. The gene discussed is POMC; the disease is pituitary adenocarcinoma.